1. Cyclosporin A immunosuppression, Epstein-Barrantibodyand lymphoma;Nagington, J.; Gray, J.;Lancet,1980
2. B-cell lymphoma in organ transplant recipients. Semin Thorac Cardiovasc Surg;Thomas, J.A.; Crawford, D.H.,1990
3. The pathology ofposttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisolone immunosuppression;Nalesnik, M.A.; Jaffe, R.; Starzl, T.; Demetris, A.J.; Porter, K.; Burnham, J.A.;Am J Pathol,1988
4. Characterisation of the major EpsteinBarr virus-specific RNA in Burkitt's lymphoma-derived cells;Arrand, JR, Rymo; L.;J Virol,1982
5. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression;Armitage, J.M.; Kormos, R.L.; Stuart, S.; Fricker, F.J.; Griffith, B.P.; Nalenik, M.;J Heart Lung Transplant,1991